SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-044168
Filing Date
2024-11-08
Accepted
2024-11-08 08:30:38
Documents
16
Period of Report
2024-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50191
2 ex1-1.htm EX-1.1 562022
3 ex99-1.htm EX-99.1 14153
4 ex99-1_001.jpg GRAPHIC 10566
  Complete submission text file 0001493152-24-044168.txt   943857

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sonn-20241106.xsd EX-101.SCH 3018
6 XBRL LABEL FILE sonn-20241106_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE sonn-20241106_pre.xml EX-101.PRE 24167
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3750
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 241438110
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)